Human Genetics Market Research Report - Forecast to 2027

Human Genetics Market Research Report: By Instrument (Accessories, Device), Method (Prenatal, Molecular, Cytogenetic, Presymptomatic), Application (Forensic Research, Cancer, Cardiovascular Diseases), and End User (Hospitals) – Global Forecast Till 2027

ID: MRFR/LS/0243-HCR | February 2021 | Region: Global | 80 pages

Market scenario


Genetics is nothing but the study of genes, their functions and effects. Molecular genetics, developmental genetics, population genetics and quantitative genetics, and human genetics are various types of genetic studies. Human genetics is the study of inheritance in human beings, i.e., it is the study of inheritance of characteristics in children from parents. It includes the study of gene expression, gene structure, mutation analysis, cytogenetics and genomic imaging, genome structure and organization, genetic and physical mapping, disease association studies, molecular diagnostics, genetics of complex diseases, epistatic interactions, and various other concepts. It also helps to determine various genetic factors responsible for diseases. It offers various advantages such as identification and diagnosis and treatment of various diseases such as cancer, cardiovascular diseases, and other genetic diseases.


The global human genetics market is driven by the increasing number of patients with genetic diseases and increasing healthcare expenditure by major economies across the globe.  Furthermore, the growing awareness about genetic diseases, increasing investments in research and development, and rising government support fuel the market growth. However, various factors restrain the growth of the market such as higher cost of instruments and lack of skilled professionals.


Global Human Genetics Market is expecting a healthy growth at a CAGR of 11.5% during the forecast period.


Intended Audience



  • Research and Development (R&D) Companies

  • Genetics & Genomic Industries

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Figure 1- Global Human Genetics Market, by Region


 human genetics market


Source: Annual reports, press release, white paper, company presentation


Segmentation


The global human genetics market is segmented by instruments, methods, applications, and end-users.


On the basis of instruments, it is segmented into accessories and devices.


On the basis of methods, it is segmented into prenatal, molecular, cytogenetic, and presymptomatic.


On the basis of applications, it is segmented into forensic research, cancer, cardiovascular diseases, diabetes, genetic diseases, and others.


On the basis of end-users, it is segmented into hospitals, forensic laboratories, research centers, and others.


 Market Assessment


 human genetics Assessment


Source; World Health Organization (WHO, white paper, company presentation, annual reports


Regional analysis


America is the largest market for human genetics owing to the development in the diagnostics and medical technology and extensive use of new technologies in genetics. Additionally, the presence of key players in the market also fuels the market growth. The U.S. is the largest market for human genetics with an increase in the number of studies in genetics and its importance in healthcare.


The European market for human genetics is driven by the rising prevalence of different chronic genetic diseases and increasing government support for research and development activities. In Germany, being the largest market, the growth is governed by the rising focus on research activities by major market players in the field of genetics and technological advancement.


In Asia Pacific, the market is fueled by the increasing awareness about research in genetic diseases and steady rise in the prevalence of genetic diseases. Major countries contributing to the market growth are China, Japan, and India due to increasing availability of research facilities and presence of skilled workforce such as research scientists and others. Additionally, the increasing number of research institutes focusing on the diagnosis and treatment of genetic diseases with the help of human genetics and increasing availability of funds for research in the field of genetics support the growth of the market.


The Middle East and Africa holds the least share in the global human genetics market and shows a steady growth due to the rising demand for healthcare services and research activities, poor economic condition, and less development in medical facilities, especially, in Africa.


Key players


Some of the major players in the global human genetics market are Agilent Technologies (U.S.), Bode Technology (U.S.), GE Healthcare (U.K.), Illumina (U.S.), LGC Forensics (U.K.), Orchid Cellmark, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN N.V. (Netherlands), and Thermo Fisher Scientific, Inc. (U.S.).



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   11.5% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Instrument, Method, Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Agilent Technologies (U.S.), Bode Technology (U.S.), GE Healthcare (U.K.), Illumina (U.S.), LGC Forensics (U.K.), Orchid Cellmark, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN N.V. (Netherlands), and Thermo Fisher Scientific, Inc. (U.S.).
  Key Market Opportunities   Increasing number of patients with genetic diseases and increasing healthcare expenditure by major economies across the globe
  Key Market Drivers

  • Growing awareness about genetic diseases
  • Increasing investments in research and development
  • Rising government support fuel


  • Table of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Human Genetics Market, by Method

    6.1 Introduction

    6.2 Cytogenetic

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Molecular

    6.3.1 Market Estimates & Forecast, 2020-2027

    6.4 Presymptomatic

    6.4.1 Market Estimates & Forecast, 2020-2027

    6.5 Prenatal

    6.5.1 Market Estimates & Forecast, 2020-2027

    7. Global Human Genetics Market, by Product

    7.1 Introduction

    7.2 Consumables

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Devices

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Accessories

    7.4.1 Market Estimates & Forecast, 2020-2027

    8. Global Human Genetics Market, by Application

    8.1 Introduction

    8.2 Research

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Diagnostic

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Forensic Science

    8.4.1 Market Estimates & Forecast, 2020-2027

    9. Global Human Genetics Market, by End-User

    9.1 Introduction

    9.2 Hospital and Clinics

    9.2.1 Market Estimates & Forecast, 2020-2027

    9.3 Diagnostic Centers

    9.3.1 Market Estimates & Forecast, 2020-2027

    9.4 Research Centers

    9.4.1 Market Estimates & Forecast, 2020-2027

    9.5 Forensic Departments

    9.5.1 Market Estimates & Forecast, 2020-2027

    10. Global Human Genetics Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 U.K.

    10.3.1.4 Italy

    10.3.1.5 Spain

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic of Korea

    10.4.6 Rest of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of the Middle East & Africa

    11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    12 Company Profiles

    12.1 Agilent Technologies

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 Key Developments

    12.2 Bode Technology

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.3 GE Healthcare

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.4 Illumina

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.5 LGC Forensics

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.6 Orchid Cellmark, Inc.

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 Promega Corporation

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.8 Others

    13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Human Genetics Industry

    14 Appendix


    LIST OF TABLES

    Table 1 Human Genetics Industry Synopsis, 2020-2027

    Table 2 Global Human Genetics Market Estimates & Forecast, 2020-2027, (USD Million)

    Table 3 Global Human Genetics Market, by Region, 2020-2027, (USD Million)

    Table 4 Global Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 5 Global Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 6 Global Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 7 Global Human Genetics Market, by End-User, 2020-2027, (USD Million)

    Table 8 North America Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 9 North America Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 10 North America Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 11 North America Human Genetics Market, by End-User, 2020-2027, (USD Million)

    Table 12 US Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 13 US Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 14 US Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 15 US Human Genetics Market, by End-User, 2020-2027, (USD Million)

    Table 16 Canada Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 17 Canada Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 18 Canada Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 19 Canada Human Genetics Market, by End-User, 2020-2027, (USD Million)

    Table 20 South America Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 21 South America Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 22 South America Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 23 South America Human Genetics Market, by End-User, 2020-2027, (USD Million)

    Table 24 Europe Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 25 Europe Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 26 Europe Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 27 Europe Human Genetics Market, by End-User, 2020-2027, (USD Million)

    Table 28 Western Europe Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 29 Western Europe Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 30 Western Europe Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 31 Western Europe Human Genetics Market, by End-User, 2020-2027, (USD Million)

    Table 32 Eastern Europe Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 33 Eastern Europe Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 34 Eastern Europe Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 35 Eastern Europe Human Genetics Market, by End-User, 2020-2027, (USD Million)

    Table 36 Asia Pacific Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 37 Asia Pacific Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 38 Asia Pacific Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 39 Asia Pacific Human Genetics Market, by End-User, 2020-2027, (USD Million)

    Table 40 Middle East & Africa Human Genetics Market, by Method, 2020-2027, (USD Million)

    Table 41 Middle East & Africa Human Genetics Market, by Product, 2020-2027, (USD Million)

    Table 42 Middle East & Africa Human Genetics Market, by Application, 2020-2027, (USD Million)

    Table 43 Middle East & Africa Human Genetics Market, by End-User, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Human Genetics Market

    Figure 3 Segmentation Market Dynamics for Human Genetics Market

    Figure 4 Global Human Genetics Market Share, by Product 2016

    Figure 5 Global Human Genetics Market Share, by Application 2016

    Figure 6 Global Human Genetics Market Share, by End-User, 2016

    Figure 7 Global Human Genetics Market Share, by Region, 2016

    Figure 8 North America Human Genetics Market Share, by Country, 2016

    Figure 9 Europe Human Genetics Market Share, by Country, 2016

    Figure 10 Asia Pacific Human Genetics Market Share, by Country, 2016

    Figure 11 Middle East & Africa Human Genetics Market Share, by Country, 2016

    Figure 12 Global Human Genetics Market: Company Share Analysis, 2016 (%)

    Figure 13 AGILENT TECHNOLOGIES: Key Financials

    Figure 14 AGILENT TECHNOLOGIES: Segmental Revenue

    Figure 16 AGILENT TECHNOLOGIES: Geographical Revenue

    Figure 17 Bode Technology: Key Financials

    Figure 18 Bode Technology: Segmental Revenue

    Figure 19 Bode Technology: Geographical Revenue

    Figure 20 GE Healthcare: Key Financials

    Figure 21 GE Healthcare: Segmental Revenue

    Figure 22 GE Healthcare: Geographical Revenue

    Figure 23 QIAGEN N.V.: Key Financials

    Figure 24 QIAGEN N.V.: Segmental Revenue

    Figure 25 QIAGEN N.V.: Geographical Revenue

    Figure 26 Orchid Cellmark, Inc.: Key Financials

    Figure 27 Orchid Cellmark, Inc.: Segmental Revenue

    Figure 28 Orchid Cellmark, Inc.: Geographical Revenue

    Figure 29 LGC Forensics: Key Financials

    Figure 30 LGC Forensics: Segmental Revenue

    Figure 31 LGC Forensics: Geographical Revenue